Related content

Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects

By Gerson Myron   Dwivedi Alok   Abdallah Mouhamad   Shukla Rakesh   Jacobson Arnold  

Journal of Nuclear Cardiology, Vol. 20, Iss. 4, 2013-08 ,pp. : 592-599

Springer Publishing Company

Access to resources Recommend Favorite

How to use myocardial 123 I-MIBG scintigraphy in chronic heart failure

By Agostini Denis  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 4, 2009-04 ,pp. : 555-559

Springer Publishing Company

Access to resources Recommend Favorite

Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence

By Yamashina Shohei   Yamazaki Jun-ichi  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 10, 2004-10 ,pp. : 1353-1355

Springer Publishing Company

Access to resources Recommend Favorite

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

By Bax Jeroen   Boogers Mark   Henneman Maureen  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 532-534

Springer Publishing Company

Access to resources Recommend Favorite

Standardization of the heart-to-mediastinum ratio of 123 I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations

By Matsuo Shinro  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 4, 2009-04 ,pp. : 560-566

Springer Publishing Company

Access to resources Recommend Favorite